Compare ATYR & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | LSE |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2M | 74.4M |
| IPO Year | 2015 | 2024 |
| Metric | ATYR | LSE |
|---|---|---|
| Price | $0.88 | $4.45 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $4.20 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 9.8K |
| Earning Date | 03-12-2026 | 03-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $190,000.00 | ★ $48,335,553.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18,728.88 | N/A |
| P/E Ratio | ★ N/A | $61.61 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $3.80 |
| 52 Week High | $7.29 | $14.99 |
| Indicator | ATYR | LSE |
|---|---|---|
| Relative Strength Index (RSI) | 54.93 | 50.02 |
| Support Level | $0.82 | $4.35 |
| Resistance Level | $0.94 | $4.54 |
| Average True Range (ATR) | 0.10 | 0.33 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 54.37 | 53.59 |
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.